News
Important Only
Gms Inc - Co To Pay Home Depot $147.5 Million Termination Fee If Merger Fails - SEC Filing
GMS Inc GMS.N:GMS INC - CO TO PAY HOME DEPOT $147.5 MILLION TERMINATION FEE IF MERGER FAILS - SEC FILINGGMS INC - HOME DEPOT TO PAY CO $230 MILLION TERMINATION FEE IF MERGER FAILS - SEC FILINGSource text: [ID:n0001104659-25-063833]Reuters
Mon, Jun 30
Joby Aviation: Construction Of Commercial Vertiport Site In Partnership With Skyports Infrastructure On Track For Q1'26 Completion
June 30 (Reuters) - Joby Aviation Inc JOBY.N:JOBY AVIATION INC: CONSTRUCTION OF COMMERCIAL VERTIPORT SITE IN PARTNERSHIP WITH SKYPORTS INFRASTRUCTURE ON TRACK FOR Q1'26 COMPLETIONJOBY AVIATION INC: DELIVERS FIRST AIRCRAFT TO UAE & BEGINS COMMERCIAL MARKET READINESS WORKReuters
Mon, Jun 30
Highpeak Energy, Inc. Announces Proposed Aggregate $725 Million Private Offering Of Senior Notes
Highpeak Energy Inc HPK.O:HIGHPEAK ENERGY, INC. ANNOUNCES PROPOSED AGGREGATE $725 MILLION PRIVATE OFFERING OF SENIOR NOTESHIGHPEAK ENERGY INC - TO OFFER $725 MILLION SENIOR NOTES DUE 2030Reuters
Mon, Jun 30
Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
UNITY Biotechnology Inc UBX.O:UNITY BIOTECHNOLOGY INC - BOARD APPROVES PLAN OF DISSOLUTION - SEC FILINGUNITY BIOTECHNOLOGY INC - ANIRVAN GHOSH STEPS DOWN AS CEO OF UNITY BIOTECHNOLOGY - SEC FILINGUNITY BIOTECHNOLOGY INC - LYNNE SULLIVAN STEPS DOWN AS CFO OF UNITY BIOTECHNOLOGY - SEC FILINGUNITY BIOT...Reuters
Mon, Jun 30
23AndMe Receives Court Approval For Sale To TTAM Research Institute, A Nonprofit Public Benefit Corporation
June 30 (Reuters) - 23andMe Holding Co MEHCQ.PK:23ANDME RECEIVES COURT APPROVAL FOR SALE TO TTAM RESEARCH INSTITUTE, A NONPROFIT PUBLIC BENEFIT CORPORATION23ANDME - TTAM WILL ACQUIRE SUBSTANTIALLY ALL OF ASSETS OF 23ANDME FOR A PURCHASE PRICE OF $305 MILLION.Reuters
Mon, Jun 30
The Home Depot Enters Into Agreement For Srs Distribution To Acquire Gms
Home Depot Inc HD.N:THE HOME DEPOT ENTERS INTO AGREEMENT FOR SRS DISTRIBUTION TO ACQUIRE GMSHOME DEPOT INC - DEAL VALUED AT $5.5 BILLION, $110 PER SHAREHOME DEPOT INC - DEAL FUNDED THROUGH CASH AND DEBTHOME DEPOT INC - DEAL EXPECTED TO BE ACCRETIVE TO EPS IN FIRST YEARReuters
Mon, Jun 30
U Power Enters Macau Market Signs Of Its First Electric Service Provider ("ESP") Agreement In Macau
June 30 (Reuters) - U Power Ltd UCAR.O:U POWER ENTERS MACAU MARKET; SIGNS OF ITS FIRST ELECTRIC SERVICE PROVIDER ("ESP") AGREEMENT IN MACAUU POWER LTD: OVER 3 YRS, ESP PARTNER EXPECTS TO BE BUYING, SELLING ABOUT 600 FOUR-WHEELED AND 5,000 TWO-WHEELED VEHICLESReuters
Mon, Jun 30
Tyra Biosciences Doses First Patient In Phase 2 Study Of Tyra-300 In Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer (Surf302)
Tyra Biosciences Inc TYRA.O:TYRA BIOSCIENCES DOSES FIRST PATIENT IN PHASE 2 STUDY OF TYRA-300 IN LOW-GRADE INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER (SURF302)TYRA BIOSCIENCES INC - INITIAL 3-MONTH CR DATA EXPECTED IN 1H 2026Reuters
Mon, Jun 30
Avant Technologies And JV Partner, Ainnova, Prepare For Key FDA Milestone With Next Week's Pre-Submission Meeting
Avant Technologies Inc AVAI.PK:AVANT TECHNOLOGIES AND JV PARTNER, AINNOVA, PREPARE FOR KEY FDA MILESTONE WITH NEXT WEEK'S PRE-SUBMISSION MEETINGAVANT TECHNOLOGIES INC - FDA PRE-SUBMISSION MEETING SET FOR JULY 7Reuters
Mon, Jun 30
Intensity Therapeutics, Inc. Announces That Int230-6 Achieved 100% Complete Response Rate In Preclinical Models Of Malignant Peripheral Nerve Sheath Tumors (Mpnst)
Intensity Therapeutics Inc INTS.O:INTENSITY THERAPEUTICS, INC. ANNOUNCES THAT INT230-6 ACHIEVED 100% COMPLETE RESPONSE RATE IN PRECLINICAL MODELS OF MALIGNANT PERIPHERAL NERVE SHEATH TUMORS (MPNST)INTENSITY THERAPEUTICS INC - INT230-6 SHOWS COMPLETE RESPONSE IN 21 DAYS IN MPNST STUDYReuters
Mon, Jun 30
23Andme Receives Court Approval For Sale To Ttam Research Institute, A Nonprofit Public Benefit Corporation
23andMe Holding Co MEHCQ.PK:23ANDME RECEIVES COURT APPROVAL FOR SALE TO TTAM RESEARCH INSTITUTE, A NONPROFIT PUBLIC BENEFIT CORPORATION23ANDME HOLDING CO - TTAM TO BUY 23ANDME ASSETS FOR $305 MILLIONReuters
Mon, Jun 30
Eve Air Mobility, Aerosolutions, And Bluenest By Globalvia Sign Letter Of Intent For Up To 50 Evtols And Techcare Services
Eve Holding Inc EVEX.N:EVE AIR MOBILITY, AEROSOLUTIONS, AND BLUENEST BY GLOBALVIA SIGN LETTER OF INTENT FOR UP TO 50 EVTOLS AND TECHCARE SERVICESEVE HOLDING INC - AGREEMENT TO DEVELOP ADVANCED AIR MOBILITY ECOSYSTEM IN COSTA RICAReuters
Mon, Jun 30
Takeda Announces U.S. FDA Approval Of Gammagard Liquid Erc, The Only Ready-To-Use Liquid Immunoglobulin Therapy With Low Immunoglobulin A (Iga) Content1
Takeda Pharmaceutical Co Ltd 4502.T:TAKEDA ANNOUNCES U.S. FDA APPROVAL OF GAMMAGARD LIQUID ERC, THE ONLY READY-TO-USE LIQUID IMMUNOGLOBULIN THERAPY WITH LOW IMMUNOGLOBULIN A (IGA) CONTENT1TAKEDA PHARMACEUTICAL CO LTD - TO DISCONTINUE FIRST-GENERATION LOW-IGA PRODUCTTAKEDA PHARMACEUTICAL CO LTD - GAM...Reuters
Mon, Jun 30
Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting On Neurofilament Biomarker Analysis Plan And Confirms Two Additional FDA Meetings
Clene Inc. CLNN.O:CLENE PROVIDES REGULATORY UPDATE FOLLOWING CONSTRUCTIVE FDA TYPE-C MEETING ON NEUROFILAMENT BIOMARKER ANALYSIS PLAN AND CONFIRMS TWO ADDITIONAL FDA MEETINGSCLENE INC. - CONFIRMS TWO ADDITIONAL FDA MEETINGS FOR Q3 2025CLENE INC. - ON TRACK FOR ALS NDA SUBMISSION IN Q4 2025CLENE INC....Reuters
Mon, Jun 30
